Canadian cannabis producer Cannara Biotech’s profit rises in quarter

Montreal cannabis producer Cannara Biotech reported a profit of 2.9 million Canadian dollars ($2.2 million) in its third quarter that ended in May, according to its recently released financial statements.

The net income for the company’s third quarter is 107% higher than the figure for the same quarter in 2022, when Cannara reported a CA$1.4 million profit, according to a news release.

Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) – another measure of profitability – for the quarter amounted to a positive CA$3.9 million.

Adjusted EBITDA through Cannara’s first three quarters of its fiscal year reached CA$8.6 million.

Cannara’s net sales in 2023’s March-May quarter increased by 57% to CA$15.9 million compared to the same three-month period in 2022.

Net revenue for the first nine months of fiscal 2023 jumped to CA$39.3 million – 63% higher over the same nine-month period last year.

Money left over after paying operating expenses and capital expenditures – or free cash flow – for the third quarter was CA$3.2 million, a 113% increase from CA$1.5 million in the third quarter of 2022.

“This past quarter was a tremendous success as Cannara grew its market share by more than 30% in Quebec and in Ontario, along with growing sales in (British Columbia) and the commencement of sales in a new market, Alberta, the second largest cannabis market in Canada,” CEO Zohar Krivorot said in a statement.

The company said its market share in Quebec grew to 9.3%, up from 7%.

In Ontario, the largest cannabis market in Canada, Cannara held a market share of 2.7%.

Cannara also said it increased its number of employees by 29% to support operational growth. The company employed 270 people as of May 2023.

The producer had CA$4 million in cash at the end of the quarter.

Cannara’s shares trade as LOVE on the Toronto Venture Exchange.

Source: https://mjbizdaily.com/canadian-cannabis-producer-cannara-biotech-profit-rises-in-quarter/